Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|November 1, 1985
Excretion of doxepin and N-desmethyldoxepin in human milkJ Kemp, K F Ilett, J Booth, et al.
Optics Letters|November 1, 2014
Quantitative phase imaging with partially coherent illuminationT H Nguyen, C Edwards, L L Goddard, et al.
Therapeutic Drug Monitoring|August 1, 1992
Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme-multiplied immunoassayL J Dusci, L P Hackett, G M Chiswell, et al.
Therapeutic Drug Monitoring|December 1, 1987
High-performance liquid chromatographic method for measurement of pentamidine in plasma and its application in an immunosuppressed patient with renal dysfunctionL J Dusci, L P Hackett, A M Forbes, et al.
Therapeutic Drug Monitoring|December 1, 1996
Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centersN C Saccoia, L P Hackett, R G Morris, et al.
British Journal of Clinical Pharmacology|December 12, 2001
Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosingE J Begg, T J Malpas, L P Hackett, et al.
Therapeutic Drug Monitoring|November 1, 1991
Disposition of dothiepin after overdose: effects of repeated-dose activated charcoalK F Ilett, L P Hackett, L J Dusci, et al.
Clinical Pharmacokinetics|September 1, 1995
Antidepressant toxicity and the need for identification and concentration monitoring in overdoseB M Power, L P Hackett, L J Dusci, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics of quetiapine in overdose and the effect of activated charcoalG K Isbister, L E Friberg, L P Hackett, et al.
Optics Letters|November 1, 2014
Epi-illumination diffraction phase microscopy with white lightC Edwards, B Bhaduri, B G Griffin, et al.
Pageof 14